PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 91 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 42.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $114,000 | -43.6% | 50,000 | -10.7% | 0.02% | -21.1% |
| Q4 2019 | $202,000 | +5.8% | 56,000 | 0.0% | 0.02% | -9.5% |
| Q3 2019 | $191,000 | -27.4% | 56,000 | 0.0% | 0.02% | -19.2% |
| Q2 2019 | $263,000 | +32.8% | 56,000 | -5.4% | 0.03% | +13.0% |
| Q1 2019 | $198,000 | -73.5% | 59,189 | -78.9% | 0.02% | -76.5% |
| Q4 2018 | $747,000 | +295.2% | 281,000 | +1024.0% | 0.10% | +366.7% |
| Q4 2017 | $189,000 | +21.9% | 25,000 | 0.0% | 0.02% | +5.0% |
| Q3 2017 | $155,000 | +22.0% | 25,000 | 0.0% | 0.02% | +17.6% |
| Q2 2017 | $127,000 | +95.4% | 25,000 | 0.0% | 0.02% | +88.9% |
| Q1 2017 | $65,000 | +44.4% | 25,000 | 0.0% | 0.01% | +50.0% |
| Q4 2016 | $45,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 1,360,000 | $6,895,000 | 5.06% |
| Omega Fund Management, LLC | 778,230 | $3,946,000 | 2.91% |
| BVF INC/IL | 5,346,838 | $27,108,000 | 2.65% |
| Virtus ETF Advisers LLC | 152,550 | $773,000 | 0.68% |
| SPHERA FUNDS MANAGEMENT LTD. | 842,632 | $4,272,000 | 0.59% |
| Tekla Capital Management LLC | 2,087,380 | $10,583,000 | 0.40% |
| Schonfeld Strategic Advisors LLC | 828,600 | $4,201,000 | 0.23% |
| Orbimed Advisors | 3,140,000 | $15,920,000 | 0.19% |
| Lombard Odier Asset Management (USA) Corp | 563,878 | $2,859,000 | 0.19% |
| Rhenman & Partners Asset Management AB | 300,000 | $1,521,000 | 0.16% |